Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights
International Journal of Molecular Sciences · 07.04.2026 · 27 (7) · 3341
DOI: 10.3390/ijms27073341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.04.2026. Verfasst von Efthalia Angelopoulou und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Neurology, Aiginition University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece. Hauptthemen laut MEDLINE: Tauopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mild behavioral impairment (MBI) is a clinical syndrome characterized by the late-life onset and persistence of neuropsychiatric symptoms (NPSs), representing a change from longstanding behavior or personality and considered a potential prodrome of neurodegenerative disease. MBI is classified into five domains: decreased motivation, affective dysregulation, impulse dyscontrol, social inappropriateness, and psychotic symptoms. In this narrative review, we synthesize clinical, neuroanatomical, and molecular evidence linking MBI to the spectrum of tauopathies, including Alzheimer’s disease (AD), frontotemporal spectrum disorders (FTSDs), and primary four-repeat tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Emerging evidence suggests that early behavioral symptoms associated with MBI may reflect the selective vulnerability of frontolimbic, salience, default mode, and frontostriatal networks to tau-mediated neurodegeneration. Mechanistically, converging findings support roles for tau-related synaptic dysfunction, including synaptotoxic soluble tau species, cytoskeletal and axonal transport disruption, monoaminergic neurotransmitter imbalance in brainstem systems, and neuroinflammatory and glial pathways. We also highlight genotype-related behavioral profiles in genetic frontotemporal lobar degeneration and discuss how scalable blood-based biomarkers, including neurofilament light chain, glial fibrillary acidic protein, and plasma phospho-tau species, may complement MBI-based phenotyping for differential diagnosis and prognostic stratification in clinical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1st Department of Neurology, Aiginition University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
- Third Age Day Care Center IASIS, 16562 Athens, Greece.
- School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
ORCID-Profile: Efthalia Angelopoulou, John Papatriantafyllou, Sokratis Papageorgiou, Chiara Villa
Zitieren
APA
Angelopoulou, E., Papatriantafyllou, J., Papageorgiou, S., & Villa, C. (2026). Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights. International Journal of Molecular Sciences, 27(7), 3341. https://doi.org/10.3390/ijms27073341
Vancouver
Angelopoulou E, Papatriantafyllou J, Papageorgiou S, Villa C. Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights. International Journal of Molecular Sciences. 2026;27(7):3341. doi:10.3390/ijms27073341
BibTeX
@article{Angelopoulou2026,
author = {Angelopoulou, Efthalia and Papatriantafyllou, John and Papageorgiou, Sokratis and Villa, Chiara},
title = {Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3341},
doi = {10.3390/ijms27073341}
}
EUVIMED